Overall, abnormal insulin signaling, through a combined effect on both insulin resistance and deficient insulin secretion, becomes a key factor in the pathogenesis of type 2 diabetes, atherogenic dyslipidemia, metabolic syndrome and all related metabolic and cardiovascular abnormalities. The gene discussed is INS; the disease is Insulin resistance.